| ARID1A altered in cohorts of …ALTERED_INderived24 of 24show fewer |
|---|
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 136 / 247 cases (55 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 793 / 1,882 cases (42 %) · ssm · ucec_ancestry_cds_msk_2023 · largest of 10 cohorts | — | — | Endometrial Carcinoma | 10 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Basal Cell Carcinoma 86 / 293 cases (29 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 127 / 474 cases (27 %) · ssm · blca_msk_tcga_2020 · largest of 13 cohorts | — | — | Bladder Urothelial Carcinoma | 13 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Pelvis and Ureter Urothelial Carcinoma 26 / 119 cases (22 %) · ssm · utuc_msk_2019 · largest of 2 cohorts | — | — | Renal Pelvis and Ureter Urothelial Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 102 / 478 cases (21 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gallbladder Carcinoma 50 / 244 cases (20 %) · ssm · gbc_mskcc_2022 · largest of 2 cohorts | — | — | Gallbladder Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 106 / 518 cases (20 %) · ssm · stes_tcga_pub · largest of 3 cohorts | — | — | Gastroesophageal Junction Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 80 / 417 cases (19 %) · ssm · chol_icgc_2017 · largest of 3 cohorts | — | — | Cholangiocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Intrahepatic Cholangiocarcinoma 78 / 412 cases (19 %) · ssm · ihch_msk_2021 · largest of 2 cohorts | — | — | Intrahepatic Cholangiocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 226 / 1,370 cases (16 %) · ssm · hcc_msk_2024 · largest of 8 cohorts | — | — | Hepatocellular Carcinoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 94 / 696 cases (14 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 56 / 429 cases (13 %) · ssm · coad_tcga_gdc · largest of 3 cohorts | — | — | Colon Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 912 / 7,237 cases (13 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Adenoid Cystic Carcinoma 120 / 1,049 cases (11 %) · ssm · acc_2019 | — | — | Adenoid Cystic Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 80 / 755 cases (11 %) · ssm · mbn_mdacc_2013 · largest of 3 cohorts | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Large B-Cell Lymphoma Unclassifiable 96 / 1,001 cases (9.6 %) · ssm · dlbcl_duke_2017 | — | — | Diffuse Large B-Cell Lymphoma Unclassifiable | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 104 / 1,134 cases (9.2 %) · ssm · crc_msk_2017 · largest of 8 cohorts | — | — | Colorectal Adenocarcinoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 279 / 3,879 cases (7.2 %) · ssm · breast_msk_2025 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 177 / 2,653 cases (6.7 %) · ssm · luad_mskcc_2023_met_organotropism · largest of 2 cohorts | — | — | Lung Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Pancreatic Adenocarcinoma 24 / 412 cases (5.8 %) · ssm · pancreas_ctdna_msk_2025 · largest of 2 cohorts | — | — | Pancreatic Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Clear Cell Renal Cell Carcinomasubtype 25 / 451 cases (5.5 %) · ssm · kirc_tcga | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 68 / 1,257 cases (5.4 %) · ssm · nsclc_ctdx_msk_2022 · largest of 3 cohorts | — | — | Lung Non-Small Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 24 / 444 cases (5.4 %) · ssm · difg_glass_2019 | — | — | Diffuse Glioma | 1 | Observed | cbioportal | graph → |